SOX2 and central nervous system cancer: Focusing on samples that harbor focal amplifications of SOX2 (amplitude log 2 (copy number/2) > 0.1), which corresponds to 9% of squamous cancers and 4% of gliomas, we profiled the averaged copy number amplitude surrounding the SOX2 locus (Fig. 1a and Supplementary Fig. 1b).